Friendly Competition Fosters Progress in Hematologic Malignancies

Retrieved on: 2021-06-28 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

Friendly Competition Fosters Progress in Hematologic Malignancies. View article details on hiswai:

Excerpt

We have monoclonal antibodies, among them the CD20 antibody rituximab [Rituxan]; this, when combined with chemotherapy, improves outcome.

Article found on: www.cancernetwork.com